Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Litzow

Showing results (141-150 of 457) with videos related to

Pageof 46
Sort By:
Transplantation and Cellular Therapy|December 30, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic ExperienceSachi Singhal, Salwa S Saadeh, Urshila Durani, et al.
Bone Marrow Transplantation|August 20, 2022
Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemiaAnmol Baranwal, Ahmad Nanaa, David Viswanatha, et al.
American Journal of Hematology|February 14, 2022
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive casesAmritpal Singh, Aref Al-Kali, Kebede H Begna, et al.
Bone Marrow Transplantation|November 1, 2020
Risk of relapse in patients receiving azithromycin after allogeneic HSCTJade L Kutzke, Julianna A Merten, Jodi L Taraba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2020
A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation PatientsLauren L Ice, Gabriel T Bartoo, Kristen B McCullough, et al.
Oncotarget|December 8, 2017
Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabineRosalie M Sterner, Kimberly N Kremer, Aref Al-Kali, et al.
JCO Precision Oncology|April 20, 2022
Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA SequencingJeremy Wang, Nickhill Bhakta, Vanessa Ayer Miller, et al.
Leukemia Research|January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2018
Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplantMaria E Torres, Shahrukh K Hashmi, Maria A Stevens, et al.
Pageof 46

Showing results (141-150 of 457) with videos related to

Sort By:
Pageof 46
Transplantation and Cellular Therapy|December 30, 2022
Allogeneic Hematopoietic Stem Cell Transplantation in the Outpatient Setting: The Mayo Clinic ExperienceSachi Singhal, Salwa S Saadeh, Urshila Durani, et al.
Bone Marrow Transplantation|August 20, 2022
Outcomes of allogeneic transplant in patients with DDX41 mutated myelodysplastic syndrome and acute myeloid leukemiaAnmol Baranwal, Ahmad Nanaa, David Viswanatha, et al.
American Journal of Hematology|February 14, 2022
Midostaurin therapy for advanced systemic mastocytosis: Mayo Clinic experience in 33 consecutive casesAmritpal Singh, Aref Al-Kali, Kebede H Begna, et al.
Bone Marrow Transplantation|November 1, 2020
Risk of relapse in patients receiving azithromycin after allogeneic HSCTJade L Kutzke, Julianna A Merten, Jodi L Taraba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 8, 2020
A Prospective Survey of Outpatient Medication Adherence in Adult Allogeneic Hematopoietic Stem Cell Transplantation PatientsLauren L Ice, Gabriel T Bartoo, Kristen B McCullough, et al.
Oncotarget|December 8, 2017
Histone deacetylase inhibitors reduce differentiating osteoblast-mediated protection of acute myeloid leukemia cells from cytarabineRosalie M Sterner, Kimberly N Kremer, Aref Al-Kali, et al.
JCO Precision Oncology|April 20, 2022
Acute Leukemia Classification Using Transcriptional Profiles From Low-Cost Nanopore mRNA SequencingJeremy Wang, Nickhill Bhakta, Vanessa Ayer Miller, et al.
Leukemia Research|January 24, 2019
The relationship between clinical trial accrual volume and outcomes in acute myeloid leukemia: A SWOG/ECOG-ACRIN study (S0106 and E1900)Bruno C Medeiros, Megan Othus, Martin S Tallman, et al.
Blood|December 13, 2005
Flow cytometric detection of circulating myeloma cells before transplantation in patients with multiple myeloma: a simple risk stratification systemDavid Dingli, Grzegorz S Nowakowski, Angela Dispenzieri, et al.
Hematology/Oncology and Stem Cell Therapy|December 15, 2018
Impact of hospital hospitality house programs on quality of life and mood of patients and caregivers after hematopoietic stem cell transplantMaria E Torres, Shahrukh K Hashmi, Maria A Stevens, et al.
Pageof 46